tambiciclib — Topline data
Q4 2026
– 28 Patients Enrolled in Phase 2 Trial of SLS009 in Newly Diagnosed First-Line AML; Topline Data Expected in Q4 2026 –Source filing
catalyst calendar
SELLAS LIFE SCIENCES GROUP INC · Data as of 2026-10-25
Q4 2026
– 28 Patients Enrolled in Phase 2 Trial of SLS009 in Newly Diagnosed First-Line AML; Topline Data Expected in Q4 2026 –Source filing